A detailed history of Argentarii, LLC transactions in Amgen Inc stock. As of the latest transaction made, Argentarii, LLC holds 1,788 shares of AMGN stock, worth $610,977. This represents 0.19% of its overall portfolio holdings.

Number of Shares
1,788
Previous 1,301 37.43%
Holding current value
$610,977
Previous $367 Million 59.4%
% of portfolio
0.19%
Previous 0.15%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 13, 2026

BUY
$290.13 - $341.71 $141,293 - $166,412
487 Added 37.43%
1,788 $585 Million
Q3 2025

Oct 27, 2025

BUY
$271.18 - $309.22 $63,456 - $72,357
234 Added 21.93%
1,301 $367 Million
Q2 2025

Jul 14, 2025

BUY
$262.28 - $309.85 $56,127 - $66,307
214 Added 25.09%
1,067 $298 Million
Q1 2025

Apr 29, 2025

SELL
$258.59 - $327.36 $133,173 - $168,590
-515 Reduced 37.65%
853 $266 Million
Q4 2024

Feb 07, 2025

BUY
$258.78 - $328.31 $354,011 - $449,128
1,368 New
1,368 $357 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $183B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Argentarii, LLC Portfolio

Follow Argentarii, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Argentarii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Argentarii, LLC with notifications on news.